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Objectives: We evaluated the feasibility, safety, and short-term efficacy of an
interventional atrial incision placed at the time of the Fontan operation to reduce the
development of intra-atrial reentrant tachycardia.
Methods: This prospective randomized blinded trial was conducted in patients with
congenital heart disease undergoing an initial lateral tunnel Fontan. Intervention
patients underwent a lateral tunnel Fontan with an interventional atrial incision/
cryoablation from the atriotomy to the right atrioventricular annulus. Controls
underwent a standard lateral tunnel Fontan. Safety of the intervention was moni-
tored. Short-term efficacy was determined by comparisons of conduction block
across the incision area and spontaneous or inducible atrial arrhythmias.
Results: There were no significant differences between intervention (n 21, median
2.4 years, range 0.8-3.9) and controls (n  21, median 2.7 years, range 1.5-13.9) in
age, type of heart disease, surgical parameters, or postoperative outcomes. Safety
parameters showed no difference between groups in number or severity of adverse
events. Short-term efficacy included evidence of conduction block with a longer
conduction time across the incision area in intervention patients (median 97 ms,
range 35-160) compared with controls (median 40 ms, range 8-77, P  .0001). No
intervention patients had spontaneous or inducible intra-atrial reentrant tachycardia
versus 2 controls (0/21 versus 2/21, P  NS).
Conclusions: An interventional atrial incision to reduce intra-atrial reentrant tachy-
cardia in the Fontan operation was feasible and safe. The intervention changed the
atrial substrate as shown by an increase in conduction time. Short-term results
showed a low incidence of intra-atrial reentrant tachycardia in all patients. Longer
follow-up is necessary to assess clinical efficacy.
Intra-atrial reentrant tachycardia (IART) is a frequent late complicationfollowing the atriopulmonary-type Fontan operation, with an estimatedprevalence of 25% by 5 years and reaching 50% by 10 years following theoperation.1-3 Current therapeutic modalities including antiarrhythmic med-ications, arrhythmia mapping and radiofrequency catheter ablation,4-8 andFontan revision surgery with a right atrial maze creation9-12 may provide
some patients with improved arrhythmia control. These modalities, however, have
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limited efficacy or significant side effects and may not be
appropriate for all patients. Current techniques of the Fontan
procedure involving a lateral tunnel or extracardiac conduit
appear to result in a lower incidence of IART13,14 but do not
entirely eliminate the risk of IART.15-17
The mechanisms causing IART in Fontan patients are
complex. Based on experience of electrophysiologic studies
and radiofrequency ablations in Fontan patients, data from
canine models, and initial studies of surgical atrial modifi-
cations in Fontan revision patients, the atrial incisions and
suture lines of the Fontan operation contribute to the devel-
opment of IART. In canine models, high-resolution epicar-
dial mapping data has suggested that the atriotomy, the
suture lines of the lateral cavopulmonary connection, and
the anatomical right atrial boundaries serve as barriers,
which themselves constitute a sufficient substrate for the
occurrence of IART.18,19 Variations in the Fontan suture
line with respect to anatomical atrial structures, such as the
crista terminalis, have been shown to affect the development
of IART circuits.18
A prophylactic atrial incision placed in such a way as to
disrupt the potential circuits about the atriotomy line has
been shown to prevent IART from developing in animal
studies.19 We hypothesized that an interventional atrial in-
cision, similar to that used in canine models, placed at the
time of the initial Fontan operation would cause atrial
conduction block, prevent IART circuits from developing
around the atriotomy or right atrioventricular annulus, and
reduce the overall incidence of IART. This study was de-
signed to: (1) determine the feasibility of placing the inter-
ventional incision in patients with heterogeneous anatomy,
(2) assess the safety of the intervention, and (3) document
short-term efficacy.
Materials and Methods
Study Design
This is a prospective, randomized, double-blinded study in patients
with univentricular hearts who underwent the Fontan procedure at
Children’s Hospital, Boston, between October 1999 and May
2001. The study was approved by the Committee on Clinical
Investigation.
Subject Selection
Criteria for inclusion in this study included: (1) complex congen-
ital heart disease consisting of single ventricle physiology and (2)
planned lateral tunnel Fontan operation at Children’s Hospital,
Boston. Exclusion criteria were: (1) any cardiac anatomy that did
not have a clearly defined right atrioventricular annulus (eg, tri-
cuspid atresia) or (2) a history of a prior Fontan operation. An
attempt was made to approach and discuss study participation with
all patients who fulfilled these criteria and had their Fontan oper-
ation during the study period. Informed consent/assent was ob-
tained from the patients and/or their guardians prior to study
participation.
Study Intervention
Patients were randomized to either control or intervention groups.
Patients in the control group underwent a conventional lateral
tunnel Fontan operation involving an intracardiac baffle created
partially by Gore-Tex (W. L. Gore & Associates, Inc, Flagstaff,
Ariz). Fenestration or nonfenestration was determined by the sur-
geon. The lateral aspect of the Fontan baffle was placed anterior
and medial to the crista terminalis. Patients in the intervention
group received a standard lateral tunnel Fontan operation with an
additional prophylactic atrial incision. (See Figure 1.) The prophy-
lactic atrial incision was placed from the atriotomy line to the right
atrioventricular annulus. The superior/inferior orientation of the
incision was variable depending on the surgeon’s decision as to the
best location for the incision and the patient’s underlying cardiac
anatomy. At the discretion of the surgeon, the prophylactic inci-
sion was brought to the atrioventricular groove either with a single
90-second cryothermal lesion (in the majority of cases) or with
careful dissection. The incision and atriotomy were then closed
with a running Prolene suture. Three temporary atrial epicardial
pacing wires were placed on the atrium at the conclusion of the
repair for both control and intervention groups. For the interven-
tion group, 2 wires were placed between the atriotomy and the
atrioventricular annulus 1 to 1.5 cm superior to the prophylactic
incision and these were brought out together to the thorax on the
patient’s right side. A third atrial wire was placed 1 to 1.5 cm
inferior to the incision and this single wire was brought to the
thorax in the center of the abdomen. This third atrial wire was used
Figure 1. Diagrammatic representation of the lateral tunnel Fon-
tan operation with the interventional atrial incision. The right
atrium is opened at the Fontan baffle suture line. The Fontan baffle
is fenestrated. The oval with the dashed lines represents the
atrial septal defect. The interventional atrial incision was created
from the Fontan baffle to the right atrioventricular valve annulus
as shown. Cryoablation was used to bring the interventional
atrial incision directly to the right atrioventricular valve without
causing damage to the right coronary artery (this area is high-
lighted by a gray circle). The placement of the temporary atrial
pacing wires are shown, with 2 wires placed superior to the
interventional incision and 1 placed inferior to the interventional
incision. IVC, inferior vena cava; SVC, superior vena cava; RAA,
right atrial appendage.
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for assessment of the interventional incision to create conduction
block. In control patients, the wires were placed in similar areas as
if an intervention had been made.
The rationale for the interventional incision is that it utilizes
aspects of the lesion from Rodefeld’s19 canine studies (incorpora-
tion of the atrial suture line and extension of the lesion to the right
atrioventricular valve annulus). The advantage of such an inter-
ventional incision is that it is a single lesion, is relatively easy to
perform, and is likely to carry a low risk of injuring the atrioven-
tricular node. A cryothermal lesion was used as a method of
“anchoring” the incision to the nonconducting boundary of the
atrioventricular groove. After dissection of the epicardial fat pad,
this lesion is placed from the endocardial surface as a method to
avoid propagation of the cryothermal injury to the right coronary
artery. Patients without a clearly defined right atrioventricular
annulus were excluded from the study secondary to concerns that
an incision brought to an ill-defined atrioventricular annulus would
have a higher potential of causing damage to the right coronary
artery and/or the atrioventricular node.
Baseline Measurements
Baseline evaluation included: (1) documentation of past medical
and surgical histories; (2) documentation of prior arrhythmias and
arrhythmia therapies; (3) electrocardiogram and 24-hour ambula-
tory electrocardiogram; (4) echocardiographic parameters of atrio-
ventricular valve regurgitation and qualitative assessment of ven-
tricular function; (5) catheterization data including systemic
oxygen saturation, atrial pressure, ventricular end-diastolic pres-
sure, cardiac index, and pulmonary vascular resistance.
Randomization and Blinding
Randomization was stratified by surgeon, so that each surgeon
performed a similar number of intervention and control Fontan
operations. Treatment assignment was not revealed until the sur-
geon had inspected the patient’s anatomy in the operating room
and assessed that the patient could be included in the study. All
parties including subjects, parents, nurses, and investigators were
blinded to the intervention with the exception of the operators who
performed the intervention and 1 study coordinator.
Operative and Postoperative Parameters
Surgical parameters of bypass and crossclamp times as well as
additional surgical interventions at the time of the Fontan opera-
tion were recorded. The primary surgical and medical teams di-
rected intraoperative and postoperative monitoring and care as
deemed appropriate. Postoperative parameters of time to extuba-
tion, days on inotropic medications, time to removal of chest tubes,
length of intensive care unit stay, and length of hospital stay were
recorded. Cardiac rhythm evaluation and management were deter-
mined by the primary medical/cardiovascular surgical team with
the assistance of a pediatric electrophysiologist.
Outcome Measures
Test of conduction across the interventional incision area. If
the prophylactic atrial incision resulted in conduction block, then
latency from pacing on 1 side of the incision to sensing on the
other involves conduction around the entire atriotomy and should
be relatively long. In control patients, or if the prophylactic inci-
sion continued to allow conduction, then conduction times across
the area would be relatively short. Efficacy of the prophylactic
incision in creating a line of conduction block was tested postop-
eratively using the temporary pacing wires. Atrial overdrive pacing
was performed using the 2 superior atrial wires and conduction
time to the single inferior wire was then measured. Next, atrial
overdrive pacing was performed at the same rate as previously but
from the single inferior wire with measurement of atrial activation
to the 2 superior atrial wires. The average latency from stimulus to
sensed atrial event was recorded as the conduction time.
Spontaneous or inducible intra-atrial reentrant tachycardia.
IART was defined as an atrial rhythm with a fixed cycle length and
P-wave morphology and with the atrial rhythm being independent
of ventricular activation. Spontaneous or clinical IART was doc-
umented as to the time from the Fontan operation, any causal
factors, and the patient’s clinical status. Inducible IART was
determined by a postoperative atrial stimulation study that was
conducted when the patient was hemodynamically stable and off
inotropic support. Atrial stimulation was delivered by a program-
mable stimulator at twice capture threshold via the 2 superior
temporary atrial pacing wires. A standard atrial stimulation proto-
col was conducted and included: (1) single, double, and triple
extrastimuli at a basic cycle length of 600, 500, or 400 ms (highest
that is still shorter than resting cycle length of the patient) and with
extrastimulus testing conducted to atrial refractoriness and (2)
rapid atrial pacing, 12 beat trains from 400 to 200 ms in 10-ms
increments. If no IART was inducible, then the atrial stimulation
protocol was repeated during infusion of isoproterenol at 0.01 to
0.02 g · kg1 · min1.
Other supraventricular tachycardia. All other forms of su-
praventricular tachycardia including ectopic atrial tachycardia,
atrioventricular nodal reentry, atrial fibrillation, or accessory path-
way-mediated tachycardia were recorded.
Sinus node dysfunction. Sinus node dysfunction was defined
as: (1) minimum or mean heart rate more than 2 standard devia-
tions below the age-adjusted mean, (2) predominant junctional
rhythm, and/or (3) sinus pause of 3 seconds or more in duration.20
The duration of sinus node dysfunction and the need for temporary
atrial pacing were documented.
Safety Assessment of Intervention
Adverse events were categorized according to a standardized list
used for reporting in the Cardiac Intensive Care Unit at Children’s
Hospital, Boston. Severity and likely relationship of adverse
events to the study intervention were determined by 3 pediatric
cardiologists not directly involved in the study who were blinded
to patient name and randomization status.
Statistical Analysis
Statistical analysis was performed using STATA statistical soft-
ware (STATA Corporation, College Station, Tex). The 2-sample t
test was used for continuous data that were normally distributed,
and the Wilcoxon rank-sum test was used for data that are not
normally distributed. The chi-square and Fisher exact test were
used as appropriate to examine categorical data.
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Results
Patient Demographics
Forty-two patients were enrolled in the study, divided
equally between intervention and control groups. Patient
demographics are outlined in Table 1. Patients in the inter-
vention group tended to be older and were significantly
taller and heavier than patients in the control group. Most
patients had a prior bidirectional cavopulmonary anastomo-
sis (19/21 in the intervention group and 18/21 in the control
group). None of the patients had a prior hemi-Fontan pro-
cedure.
Preoperative Assessment
There were no significant differences between groups in any
of the preoperative evaluations completed. (See Table 2.)
Subjects in both groups had very limited prior arrhythmia
history or arrhythmia therapies. Echocardiographic and
catheterization parameters showed that most patients were
good candidates for the Fontan operation.
Operative and Postoperative Parameters
There was no difference in bypass time between the inter-
vention group (108  20 minutes) and the control group
(100  20 minutes; P  .21). Crossclamp time was shorter
in the intervention group (51  9 minutes) compared with
the control group (58  14 minutes; P  .007). All inter-
vention and control patients, except for 1 in the control
group, received a fenestrated Fontan procedure. All patients
in the intervention group received the interventional inci-
sion.
Additional operative procedures in the intervention
group included tricuspid valvuloplasty (n  4), pulmonary
artery plasty (n 2), atrial septectomy (n 1), and ligation
of left superior vena cava to coronary sinus and unroofing of
the coronary sinus (n  1). Additional operative procedures
in the control group included atrial septectomy (n  3),
division and oversewing of the main pulmonary artery (n 
2), subaortic resection (n  1), ligation of left superior vena
cava to coronary sinus and unroofing of the coronary sinus
(n  1), and augmentation of the superior vena cava to
pulmonary artery anastomosis (n  1).
There were no statistically significant differences be-
tween intervention and control groups in the postoperative
parameters of time to extubation, number of days on ino-
tropic support, number of days of chest tube drainage,
length of stay in the intensive care unit, or length of hospital
stay.
Outcome Measures
Test of conduction across the interventional incision
area. The test of conduction across the interventional inci-
sion was a measurement of the adequacy of the incision to
block atrial conduction. There was a statistically significant
difference between this measurement in the intervention
group (median conduction time of 97 ms, range 35-160)
compared with the control group (median conduction time
40 ms, range 8-77; P  .0001). (See Figure 2.) Of the 21
intervention patients, the interventional incision was ex-
tended to the right atrioventricular groove with a cryother-
mal lesion in 17 patients and with dissection in 4. The test
of conduction measurement overlapped with the control
group in 6 intervention patients, 3 of whom had an inter-
vention that included a cryothermal lesion and 3 whom had
an intervention with simple dissection.
Spontaneous or inducible IART. See Tables 3 and 4.
No patients in the intervention group had spontaneous or
inducible IART. Rarely, patients in the control group had
spontaneous clinical IART (n  1) or inducible IART (n 
1). Treatment in both instances consisted of atrial pace
conversion. Electrophysiologic parameters as measured at
baseline or on isoproterenol and defined at postoperative
atrial stimulation study were not different between groups.
Other supraventricular tachycardia. Of the interven-
tion patients, 1 (4.8%) had atypical atrioventricular node
reentry and was treated with digoxin and sotalol. Of the
TABLE 1. Characteristics of patients in intervention and control groups
Intervention
(n  21)
Control
(n  21) P
Sex (F/M) 9:12 12:9 .54
Age (y) 2.4 (0.8-3.9) 2.7 (1.5-13.9) .09
Weight (kg) 10.8 (7.4-13.1) 13 (8.7-19.1) .03
Height (cm) 83 (67-95) 94 (75-122) .01
Cardiac anatomy .35
Hypoplastic left heart syndrome 9 5
Double-inlet left ventricle 4 5
Double-outlet right ventricle 2 7
Pulmonary atresia variants 3 2
Other 3 2
Prior cardiac operations 2 (1-3) 2 (0-3) .30
Values shown are the absolute count or median (range).
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patients in the control group, 3 (14%) had other supraven-
tricular tachycardias. One patient had a single episode of
regular narrow complex tachycardia that terminated with
adenosine and required no further medication or interven-
tion. A second patient had complex tachycardia mecha-
nisms, likely atypical atrioventricular node reentry, and was
treated with amiodarone. The third patient had been treated
for ectopic atrial tachycardia preoperatively and had ectopic
atrial tachycardia again in the postoperative setting and was
treated with propranolol.
Sinus node dysfunction and the requirement for pac-
ing. A high percentage of patients in both groups demon-
strated sinus node dysfunction at 24 hours postopera-
tively, with 38% of the intervention group and 29% of
control group (P  .51). Sinus node dysfunction largely
resolved by hospital discharge, with only 10% of interven-
tion patients and 5% of controls having sinus node dysfunc-
tion at discharge. Two patients in the intervention group
required new permanent pacing, 1 for complete atrioventricu-
lar block in a patient with L-looped ventricles and 1 for slow
sinus rhythm and frequent premature ventricular beats. No
patients in the control group required new permanent pacing.
Safety Assessment
In the intervention group, 7 adverse events occurred in 3
patients and included: urgent fenestration closure in the
catheterization laboratory (n  1), urgent fenestration cre-
ation in the catheterization laboratory (n  1), transient
isolated sinus node (n  1), readmission for effusions (n 
1), extracorporeal membrane oxygenation (n  1), multi-
system failure (n  1), and death (n  1). Only 1 adverse
event was evaluated to be probably attributed to the inter-
vention. This was a patient who had a transient functionally
isolated sinus node during the postoperative course but with
recovery of conduction across the atrium prior to discharge.
No permanent pacemaker was required. The 1 death was
assessed by our safety panel as not being associated with the
intervention. This was an 11-month-old who was consid-
ered a high-risk Fontan candidate based on preoperative
hemodynamics and the presence of arteriovenous malfor-
mations.
In the control group, 9 adverse events occurred in 6
patients and included: open chest for evacuation of clot (n
1), increased liver function tests (n  1), decreased renal
function (n  1), long intubation course/pulmonary issues
(n  1), urgent fenestration creation in the catheterization
laboratory (n  1), fungal infection (n  1), and readmis-
sion for chylous effusions (n  1).
Discussion
The objective of this trial was to assess feasibility, safety,
and short-term efficacy of an interventional atrial incision
placed at the time of the initial Fontan operation to reduce
postoperative IART. To our knowledge, this is 1 of 2
randomized controlled trials of surgical prophylaxis of
IART in the Fontan population.21 The rationale for the
interventional atrial incision was that it would create intra-
atrial conduction block to prevent IART circuits from de-
veloping around the atriotomy and right atrioventricular
annulus. The interventional incision was modeled after sim-
ilar prophylactic incisions that had been shown to be effi-
cacious in canine Fontan models. Through this trial, we
demonstrated that the interventional incision could be
TABLE 2. Comparisons of baseline cardiac parameters between intervention and control groups
Intervention
(n  21)
Control
(n  21) P
Electrophysiologic parameters
History of intra-atrial reentrant tachycardia 0 0 1.00
History of other supraventricular tachycardia 0 2 .49
Prior pacemaker 1 0 1.00
Baseline heart rate by electrocardiogram (beats/min) 103 20 102 20 .89
Echocardiographic parameters
Atrioventricular valve regurgitation .09
None 15 20
Mild 6 1
Ventricular function .61
Normal 18 20
Mildly depressed 3 1
Catheterization parameters
Systemic oxygen saturation (%) 83 5 84 3 .31
Atrial pressure (mm Hg) 6 3 6 3 .83
Ventricular end-diastolic pressure (mm Hg) 8 2 9 4 .38
Pulmonary vascular resistence (Wood units) 2.1 0.9 1.9 0.6 .40
Cardiac index 3.1 0.9 3.5 0.8 .14
Values shown are mean  SD.
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placed in all patients randomized to the intervention group
and that conduction block across the area could be achieved.
The intervention was safe for patients, as the number and
severity of adverse events documented were similar in both
control and intervention groups. Short-term efficacy showed
no difference between groups with respect to spontaneous
or inducible IART. However, in contrast to animal studies
of the lateral tunnel Fontan18,22 and previous reports of
IART inducibility in patients with classical Fontans,23 there
was a very low incidence of spontaneous or inducible IART
in either group (0% in the intervention group and 9.5% in
controls). Sinus node dysfunction was evident in both
groups in the immediate postoperative period but largely
resolved by hospital discharge.
Feasibility and Safety
We found that the interventional atrial incision was feasible
in all patients randomized to the intervention group. No
patient who underwent a lateral tunnel Fontan operation was
excluded from the study on the basis of anatomy. Placing
the interventional incision in patients with dextrocardia with
very posterior Fontan baffles was noted to be quite chal-
lenging but that it could be accomplished. Safety parameters
showed that the interventional atrial incision did not prolong
bypass or crossclamp times, lengthen recovery, or affect
morbidity or mortality.
Short-Term Efficacy
By evaluation of conduction across the interventional inci-
sion area, we showed that the interventional atrial incision
effectively created a line of conduction block. In 6 of the 21
intervention patients, however, the conduction times were
shorter and overlapped with the control group, suggesting
that the interventional incision was not complete and some
conduction across the area remained intact. In analyzing this
subgroup of intervention patients, we found that part (3 of
the 6) could be explained by the interventional incision
being created by careful dissection and without the use of a
cryothermal lesion to complete the line to the atrioventric-
ular annulus. Of note, only a minority of patients (4 of 21)
had interventions including simple dissection to the atrio-
ventricular annulus, with the majority having interventions
Figure 2. Graph showing the test of conduction across the atrium in the area of the interventional incision in both
control and intervention groups. As would be expected if the interventional atrial incision resulted in conduction
block, the measurement of conduction across the area was significantly longer in the intervention group compared
to the control group.
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that included a cryothermal lesion (17 of 21). Without a
cryothermal lesion, there potentially could be strands of
atrial tissue still intact and thus the ability to conduct across
the area. The remainder (3 of the 6) of intervention patients
that overlapped with the control group in this measurement
can only be explained by the interventional lesion not being
completely created to the atrioventricular groove, despite
the use of a cryothermal lesion. Creation of a long-lasting
and complete line of conduction block by surgical methods
may not be effective in all cases.
Early IART Following the Fontan Operation in
Canine Models and in Humans
In canine models of IART in the Fontan operation,19,24,25
IART was able to be induced with atrial pacing at baseline
or with the addition of isoproterenol in all animals studied.
In a study of human patients after the Fontan operation,26
IART was inducible in 30% of patients in the baseline state
without isoproterenol. The Fontan repairs in this study,
however, included atriopulmonary connections and other
historical modifications. In more recent retrospective re-
views of Fontan patients,3,27,28 postoperative arrhythmias
have been documented in 10% to 30% of patients. Within
those studies, if only early postoperative IART is evaluated,
then the percentage decreases to 1% to 8% of patients.
In our study, we had a very low incidence of IART,
spontaneously or inducible, in both groups despite utilizing
a standard atrial stimulation protocol, including the use of
isoproterenol. The difference between our findings and
those from prior canine or human studies may be attribut-
able to several factors. First, the lateral tunnel Fontan baffle
has had several modifications over the years and, in its
TABLE 3. Comparisons of cardiac rhythm outcome measures between intervention and control groups
Intervention
(n  21)
Control
(n  21) P
Clinical intra-atrial reentrant tachycardia 0 1 (5%) 1.00
Inducible intra-atrial reentrant tachycardia 0 1 (5%) 1.00
Other supraventricular tachycardia 1 (4.8%) 3 (14%) .61
Temporary atrial pacing 12 (57%) 8 (38%) .35
New permanent pacemaker 2 (10%) 0 .49
Sinus node dysfunction
24 hours postoperatively 10 (48%) 6 (29%) .34
24 hours postoperatively 8 (38%) 5 (24%) .51
At hospital discharge 2 (10%) 1 (5%) 1.00
Electrocardiogram at hospital discharge
Heart rate 114  23 126  18 .07
Cardiac rhythm .60
Sinus 18 19
Junctional 1 1
Paced 1 0
Values are number of patients (percent of group) with the given parameter.
TABLE 4. Comparison of postoperative atrial stimulation study between intervention and control groups
Intervention
(n  19 of 21)
Control
(n  19 of 21) P
Days postoperatively that the study was conducted 5 (1-40) 6 (2-22) .30
Baseline
Atrial effective refractory period 200 (130-230) 185 (160-290) .65
Atrioventricular nodal refractory period 266 (210-390) 235 (200-320) .40
Measured n  5 n  6
Not encountered n  14 n  13
Wenckebach cycle length 235 (190-300) 210 (180-300) .32
Isoproterenol 0.01 g · kg1 · min1
Atrial effective refractory period 190 (160-210) 190 (130-250) .42
Atrioventricular nodal refractory period 258 (210-380) 220 (210-230) .26
Measured n  5 n  5
Not encountered n  14 n  11
Wenckebach cycle length 210 (190-300) 205 (190-300) .32
Inducible intra-atrial reentrant tachycardia n  0 n  1 1.00
Data presented are median (range) or number of patients in each category.
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current form, may be less arrhythmogenic than prior Fontan
operations.13 Possible explanations for improved arrhyth-
mia outcome are the surgical technique and the location of
the lateral tunnel suture line in relation to the crista termi-
nalis.18 In all of our study patients, the lateral aspect of the
Fontan baffle was placed anterior and medial to the crista
terminalis. Second, this is one of the first studies21 to
conduct atrial stimulation studies in the immediate postop-
erative period in the Fontan population. Several natural
history studies have shown that the prevalence of IART
increases with time from the Fontan operation,1-3,15,27 sug-
gesting that other factors such as atrial hypertrophy or
fibrosis may need to occur for IART to develop. Atrial
remodeling occurs with atrial tachycardia and depends on
the underlying cardiac substrate.29 Third, the canine models
of IART in the Fontan operation may not adequately rep-
resent the acute human substrate of IART. It is also possible
that, in contrast to animal studies, Fontan suture lines con-
structed in surgical procedures in humans are not dense
barriers to atrial conduction and thus not an important
substrate for IART.
No patient in the intervention group developed IART
while 2 patients in the control group had spontaneous (n 
1) and inducible (n  1) IART, a difference that was not
statistically significant. If the incidence of early spontane-
ous and inducible IART is in fact approximately 10% in
control patients and near zero in intervention patients, as
suggested by this study, it would require about 186 random-
ized patients to determine a beneficial effect of the inter-
ventional incision, suggesting the need for a multi-institu-
tional study. The true potential clinical importance of the
interventional incision is not in the short-term but in the
efficacy at 5 to 10 years after the procedure when clinical
IART is most likely to develop. Long-term follow-up of this
cohort of patients is ongoing.
Sinus Node Dysfunction
We found a high percentage of short-term sinus node dys-
function in both groups, which resolved prior to hospital
discharge. This finding may be a result of a broad definition
of sinus node dysfunction. Any patient who had a faster
junctional rhythm in the postoperative period and required
atrial pacing was considered to have short-term sinus node
dysfunction. Many patients required temporary atrial pacing
in the postoperative time period. By hospital discharge,
however, these findings resolved and most patients were in
sinus rhythm with chronotropic competence.
Conclusions
An interventional atrial incision in the Fontan operation to
reduce IART did not prolong bypass or crossclamp times,
lengthen recovery, or affect morbidity. The interventional
incision changed the atrial substrate as shown by an increase
in conduction time across the area. Short-term results
showed low incidence of early postoperative IART in all
patients included in this trial. Longer follow-up is necessary
to assess the true efficacy of the interventional incision in
preventing spontaneous clinical IART.
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Tommy Kaplan Fellow in the Children’s Hospital Cardiovascular
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would like to thank Kimberlee Gauvreau, ScD, of Children’s
Hospital, Boston, for assistance with study design, randomization
and blinding, and statistical analysis.
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